SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.

Li Y, Oliver PG, Lu W, Pathak V, Sridharan S, Augelli-Szafran CE, Buchsbaum DJ, Suto MJ

Open source

DOI
10.1016/j.canlet.2016.12.030
Published
2017 Mar 28
Container
Cancer letters
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.canlet.2016.12.030,
  title = {SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.},
  author = {Li Y and Oliver PG and Lu W and Pathak V and Sridharan S and Augelli-Szafran CE and Buchsbaum DJ and Suto MJ},
  year = {2017},
  journal = {Cancer letters},
  doi = {10.1016/j.canlet.2016.12.030},
  url = {https://doi.org/10.1016/j.canlet.2016.12.030}
}

RIS

TY  - JOUR
TI  - SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.
AU  - Li Y
AU  - Oliver PG
AU  - Lu W
AU  - Pathak V
AU  - Sridharan S
AU  - Augelli-Szafran CE
AU  - Buchsbaum DJ
AU  - Suto MJ
PY  - 2017
JO  - Cancer letters
DO  - 10.1016/j.canlet.2016.12.030
UR  - https://doi.org/10.1016/j.canlet.2016.12.030
ER  - 

APA

Y, L., PG, O., W, L., V, P., S, S., CE, A., DJ, B., & MJ, S. (2017). SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.. Cancer letters. https://doi.org/10.1016/j.canlet.2016.12.030

Source records